Allianz Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $408K | Sell |
|
|||||
|
2024
Q3 | $1.33M | Buy |
|
|||||
|
2024
Q2 | $427K | Sell |
|
|||||
|
2024
Q1 | $616K | Sell |
|
|||||
|
2023
Q4 | $966K | Buy |
|
|||||
|
2023
Q3 | $303K | Hold |
|
|||||
|
2023
Q2 | $392K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $1.52M | Sell |
|
|||||
|
2022
Q1 | $2.6M | Buy |
|
|||||
|
2021
Q4 | $2.79M | Sell |
|
|||||
|
2021
Q3 | $3.91M | Buy |
|
|||||
|
2021
Q2 | $1.77M | Buy |
|
|||||
|
2021
Q1 | $2.07M | Sell |
|
|||||
|
2020
Q4 | $2.58M | Buy |
|
|||||
|
2020
Q3 | $1.14M | Buy |
|
|||||
|
2020
Q2 | $1.01M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $2.17M | Buy |
|
|||||
|
2018
Q4 | $823K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $354K | Sell |
|
|||||
|
2017
Q1 | $445K | Sell |
|
|||||
|
2016
Q4 | $602K | Sell |
|
|||||
|
2016
Q3 | $1.39M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $6.58M | Sell |
|
|||||
|
2015
Q4 | $16.7M | Sell |
|
|||||
|
2015
Q3 | $17.1M | Buy |
|
|||||
|
2015
Q2 | $12.4M | Buy |
|
|||||
|
2015
Q1 | $2.11M | Buy |
|